The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer – the randomized NORDIC9-study

Gabor Liposits; H. Skuladottir; Jesper Ryg; Stine Braendegaard Winther; Sören Möller; Eva Hofsli; C-H Shah; Laurids Østergaard Poulsen; A Berglund; C. Qvortrup; P. J. Osterlund; J. S. Johansen; Bengt Glimelius; Halfdan Sorbye; Per Pfeiffer

doi:10.1016/j.annonc.2022.07.483

The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer – the randomized NORDIC9-study

Gabor Liposits, H. Skuladottir, Jesper Ryg, Stine Braendegaard Winther, Sören Möller, Eva Hofsli, C-H Shah, Laurids Østergaard Poulsen, A Berglund, C. Qvortrup, P. J. Osterlund, J. S. Johansen, Bengt Glimelius, Halfdan Sorbye, Per Pfeiffer

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	345P
Tidsskrift	Annals of Oncology
Vol/bind	33
Udgave nummer	Suppl. 7
Sider (fra-til)	S694
Antal sider	1
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2022.07.483
Status	Udgivet - 2022
Begivenhed	ESMO - France, Paris Varighed: 9. sep. 2022 → 13. sep. 2022

Konference

Konference	ESMO
Lokation	France
By	Paris
Periode	09/09/2022 → 13/09/2022

Dokumenter og links

10.1016/j.annonc.2022.07.483

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Liposits, G., Skuladottir, H., Ryg, J., Winther, S. B., Möller, S., Hofsli, E., Shah, C.-H., Poulsen, L. Ø., Berglund, A., Qvortrup, C., Osterlund, P. J., Johansen, J. S., Glimelius, B., Sorbye, H., & Pfeiffer, P. (2022). The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer – the randomized NORDIC9-study. Annals of Oncology, 33(Suppl. 7), S694. Artikel 345P. https://doi.org/10.1016/j.annonc.2022.07.483

@article{0e0c06b65bea4331b5549dbe23480eb9,

title = "The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer – the randomized NORDIC9-study",

author = "Gabor Liposits and H. Skuladottir and Jesper Ryg and Winther, {Stine Braendegaard} and S{\"o}ren M{\"o}ller and Eva Hofsli and C-H Shah and Poulsen, {Laurids {\O}stergaard} and A Berglund and C. Qvortrup and Osterlund, {P. J.} and Johansen, {J. S.} and Bengt Glimelius and Halfdan Sorbye and Per Pfeiffer",

year = "2022",

doi = "10.1016/j.annonc.2022.07.483",

language = "English",

volume = "33",

pages = "S694",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 7",

note = "ESMO ; Conference date: 09-09-2022 Through 13-09-2022",

}

Liposits, G, Skuladottir, H, Ryg, J, Winther, SB, Möller, S, Hofsli, E, Shah, C-H, Poulsen, LØ, Berglund, A, Qvortrup, C, Osterlund, PJ, Johansen, JS, Glimelius, B, Sorbye, H & Pfeiffer, P 2022, 'The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer – the randomized NORDIC9-study', Annals of Oncology, bind 33, nr. Suppl. 7, 345P, s. S694. https://doi.org/10.1016/j.annonc.2022.07.483

The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer – the randomized NORDIC9-study. / Liposits, Gabor; Skuladottir, H.; Ryg, Jesper et al.
I: Annals of Oncology, Bind 33, Nr. Suppl. 7, 345P, 2022, s. S694.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer – the randomized NORDIC9-study

AU - Liposits, Gabor

AU - Skuladottir, H.

AU - Ryg, Jesper

AU - Winther, Stine Braendegaard

AU - Möller, Sören

AU - Hofsli, Eva

AU - Shah, C-H

AU - Poulsen, Laurids Østergaard

AU - Berglund, A

AU - Qvortrup, C.

AU - Osterlund, P. J.

AU - Johansen, J. S.

AU - Glimelius, Bengt

AU - Sorbye, Halfdan

AU - Pfeiffer, Per

PY - 2022

Y1 - 2022

U2 - 10.1016/j.annonc.2022.07.483

DO - 10.1016/j.annonc.2022.07.483

M3 - Conference abstract in journal

SN - 0923-7534

VL - 33

SP - S694

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 7

M1 - 345P

T2 - ESMO

Y2 - 9 September 2022 through 13 September 2022

ER -

Liposits G, Skuladottir H, Ryg J, Winther SB, Möller S, Hofsli E et al. The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer – the randomized NORDIC9-study. Annals of Oncology. 2022;33(Suppl. 7):S694. 345P. doi: 10.1016/j.annonc.2022.07.483